Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs

PURPOSE: Ketorolac 0.45% is a new formulation of topical ketorolac in which preservative (benzalkonium chloride, BAK) was removed and carboxymethylcellulose (CMC) was added to improve tolerability and reduce dosing frequency. This study compared the effects of ketorolac 0.45% on corneal wound healin...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Keping, McDermott, Mark, Villanueva, Linda, Schiffman, Rhett M, Hollander, David A
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065566/
https://www.ncbi.nlm.nih.gov/pubmed/21468332
http://dx.doi.org/10.2147/OPTH.S16778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065566/
https://www.ncbi.nlm.nih.gov/pubmed/21468332
http://dx.doi.org/10.2147/OPTH.S16778

Ejemplares similares